WWP2-WWP1 Ubiquitin Ligase Complex Coordinated by PPM1G Maintains the Balance between Cellular p73 and ΔNp73 Levels

REFERENCES

• Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809–819. http://dx.doi.org/10.1016/S0092-8674(00)80540-1.
   PubMed Web of Science ®Google Scholar
• Al-Bahlani S, Fraser M, Wong AY, Sayan BS, Bergeron R, Melino G, Tsang BK. 2011. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene 30:4219–4230. http://dx.doi.org/10.1038/onc.2011.134.
   PubMedGoogle Scholar
• Jost CA, Marin MC, Kaelin WGJr. 1997. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389:191–194. http://dx.doi.org/10.1038/38298.
   PubMed Web of Science ®Google Scholar
• Zhu J, Jiang J, Zhou W, Chen X. 1998. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58:5061–5065.
   PubMed Web of Science ®Google Scholar
• Arrowsmith CH. 1999. Structure and function in the p53 family. Cell Death Differ. 6:1169–1173. http://dx.doi.org/10.1038/sj.cdd.4400619.
   PubMedGoogle Scholar
• Araki D, Uzawa K, Watanabe T, Shiiba M, Miyakawa A, Yokoe H, Tanzawa H. 2002. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity. Int. J. Oncol. 20:355–360. http://dx.doi.org/10.3892/ijo.20.2.355.
   PubMedGoogle Scholar
• Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D, Nakagawara A. 1999. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18:1061–1066. http://dx.doi.org/10.1038/sj.onc.1202390.
   PubMedGoogle Scholar
• Shan L, Yang Q, Nakamura Y, Nakamura M, Miyauchi A, Tsujimoto M, Nakatani Y, Wakasa K, Mori I, Kakudo K. 2001. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas. Mod. Pathol. 14:273–278. http://dx.doi.org/10.1038/modpathol.3880302.
   PubMedGoogle Scholar
• Shishikura T, Ichimiya S, Ozaki T, Nimura Y, Kageyama H, Nakamura Y, Sakiyama S, Miyauchi M, Yamamoto N, Suzuki M, Nakajima N, Nakagawara A. 1999. Mutational analysis of the p73 gene in human breast cancers. Int. J. Cancer 84:321–325. http://dx.doi.org/10.1002/(SICI)1097-0215(19990621)84:3<321::AID-IJC21>3.0.CO;2-S.
   PubMedGoogle Scholar
• Ahomadegbe JC, Tourpin S, Kaghad M, Zelek L, Vayssade M, Mathieu MC, Rochard F, Spielmann M, Tursz T, Caput D, Riou G, Benard J. 2000. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers. Oncogene 19:5413–5418. http://dx.doi.org/10.1038/sj.onc.1203914.
   PubMedGoogle Scholar
• El-Naggar AK, Lai S, Clayman GL, Mims B, Lippman SM, Coombes M, Luna MA, Lozano G. 2001. p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas. Carcinogenesis 22:729–735. http://dx.doi.org/10.1093/carcin/22.5.729.
   PubMedGoogle Scholar
• Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, Wakeham A, Tsao MS, Iovanna JL, Squire J, Jurisica I, Kaplan D, Melino G, Jurisicova A, Mak TW. 2008. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 22:2677–2691. http://dx.doi.org/10.1101/gad.1695308.
   PubMed Web of Science ®Google Scholar
• Melino G, Lu X, Gasco M, Crook T, Knight RA. 2003. Functional regulation of p73 and p63: development and cancer. Trends Biochem. Sci. 28:663–670. http://dx.doi.org/10.1016/j.tibs.2003.10.004.
   PubMed Web of Science ®Google Scholar
• Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F, Hugli B, Graber HU, De Laurenzi V, Fey MF, Melino G, Tobler A. 2001. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 8:1213–1223. http://dx.doi.org/10.1038/sj.cdd.4400962.
   PubMed Web of Science ®Google Scholar
• Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM. 2002. ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J. Exp. Med. 196:765–780. http://dx.doi.org/10.1084/jem.20020179.
   PubMed Web of Science ®Google Scholar
• Stiewe T, Putzer BM. 2001. p73 in apoptosis. Apoptosis 6:447–452. http://dx.doi.org/10.1023/A:1012433522902.
   PubMedGoogle Scholar
• Rossi M, De Laurenzi V, Munarriz E, Green DR, Liu YC, Vousden KH, Cesareni G, Melino G. 2005. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J. 24:836–848. http://dx.doi.org/10.1038/sj.emboj.7600444.
   PubMed Web of Science ®Google Scholar
• Muller M, Schilling T, Sayan AE, Kairat A, Lorenz K, Schulze-Bergkamen H, Oren M, Koch A, Tannapfel A, Stremmel W, Melino G, Krammer PH. 2005. TAp73/ΔNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ. 12:1564–1577. http://dx.doi.org/10.1038/sj.cdd.4401774.
   PubMed Web of Science ®Google Scholar
• Chen C, Matesic LE. 2007. The Nedd4-like family of E3 ubiquitin ligases and cancer. Cancer Metastasis Rev. 26:587–604. http://dx.doi.org/10.1007/s10555-007-9091-x.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang Z, Wang B, Zhang J, Zhao Y, Jin Y. 2007. Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells. Mol. Cell. Biol. 27:5296–5305. http://dx.doi.org/10.1128/MCB.01667-06.
   PubMed Web of Science ®Google Scholar
• McDonald FJ, Western AH, McNeil JD, Thomas BC, Olson DR, Snyder PM. 2002. Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na+ channel. Am. J. Physiol. Renal Physiol. 283:F431–F436.
   PubMedGoogle Scholar
• Xu HM, Liao B, Zhang QJ, Wang BB, Li H, Zhong XM, Sheng HZ, Zhao YX, Zhao YM, Jin Y. 2004. Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination. J. Biol. Chem. 279:23495–23503. http://dx.doi.org/10.1074/jbc.M400516200.
   PubMedGoogle Scholar
• Maddika S, Kavela S, Rani N, Palicharla VR, Pokorny JL, Sarkaria JN, Chen J. 2011. WWP2 is an E3 ubiquitin ligase for PTEN. Nat. Cell Biol. 13:728–733. http://dx.doi.org/10.1038/ncb2240.
   PubMed Web of Science ®Google Scholar
• Chantry A. 2011. WWP2 ubiquitin ligase and its isoforms: new biological insight and promising disease targets. Cell Cycle 10:2437–2439. http://dx.doi.org/10.4161/cc.10.15.16874.
   PubMed Web of Science ®Google Scholar
• Maddika S, Chen J. 2009. Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. Nat. Cell Biol. 11:409–419. http://dx.doi.org/10.1038/ncb1848.
   PubMed Web of Science ®Google Scholar
• Zhi X, Chen C. 2012. WWP1: a versatile ubiquitin E3 ligase in signaling and diseases. Cell. Mol. Life Sci. 69:1425–1434. http://dx.doi.org/10.1007/s00018-011-0871-7.
   PubMedGoogle Scholar
• Khoronenkova SV, Dianova II, Ternette N, Kessler BM, Parsons JL, Dianov GL. 2012. ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage. Mol. Cell 45:801–813. http://dx.doi.org/10.1016/j.molcel.2012.01.021.
   PubMedGoogle Scholar
• Kimura H, Takizawa N, Allemand E, Hori T, Iborra FJ, Nozaki N, Muraki M, Hagiwara M, Krainer AR, Fukagawa T, Okawa K. 2006. A novel histone exchange factor, protein phosphatase 2Cγ, mediates the exchange and dephosphorylation of H2A-H2B. J. Cell Biol. 175:389–400. http://dx.doi.org/10.1083/jcb.200608001.
   PubMedGoogle Scholar
• Pan C, Liu HD, Gong Z, Yu X, Hou XB, Xie DD, Zhu XB, Li HW, Tang JY, Xu YF, Yu JQ, Zhang LY, Fang H, Xiao KH, Chen YG, Wang JY, Pang Q, Chen W, Sun JP. 2013. Cadmium is a potent inhibitor of PPM phosphatases and targets the M1 binding site. Sci. Rep. 3:2333. http://dx.doi.org/10.1038/srep02333.
   PubMedGoogle Scholar
• Urist M, Tanaka T, Poyurovsky MV, Prives C. 2004. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18:3041–3054. http://dx.doi.org/10.1101/gad.1221004.
   PubMed Web of Science ®Google Scholar
• Sayan BS, Yang AL, Conforti F, Tucci P, Piro MC, Browne GJ, Agostini M, Bernardini S, Knight RA, Mak TW, Melino G. 2010. Differential control of TAp73 and ΔNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc. Natl. Acad. Sci. U. S. A. 107:12877–12882. http://dx.doi.org/10.1073/pnas.0911828107.
   PubMed Web of Science ®Google Scholar
• Hosoda M, Ozaki T, Miyazaki K, Hayashi S, Furuya K, Watanabe K, Nakagawa T, Hanamoto T, Todo S, Nakagawara A. 2005. UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination. Oncogene 24:7156–7169. http://dx.doi.org/10.1038/sj.onc.1208872.
   PubMed Web of Science ®Google Scholar
• Peschiaroli A, Scialpi F, Bernassola F, Pagano M, Melino G. 2009. The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73. Oncogene 28:3157–3166. http://dx.doi.org/10.1038/onc.2009.177.
   PubMed Web of Science ®Google Scholar
• Hock A, Vousden KH. 2010. Regulation of the p53 pathway by ubiquitin and related proteins. Int. J. Biochem. Cell Biol. 42:1618–1621. http://dx.doi.org/10.1016/j.biocel.2010.06.011.
   PubMed Web of Science ®Google Scholar
• Soond SM, Smith PG, Wahl L, Swingler TE, Clark IM, Hemmings AM, Chantry A. 2013. Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer. Biochim. Biophys. Acta 1832:2127–2135. http://dx.doi.org/10.1016/j.bbadis.2013.08.001.
   PubMedGoogle Scholar